control group:Basic treatment + paxlovid (nematevir 300mg + ritonavir 100mg), q12h, 5 days

2 trials

Sponsors

Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine

Conditions

COVID-19

Unknown Phase

A real world study comparing the efficacy and safety of Huashi Baidu granule and paxlovid in the treatment of novel coronavirus pneumonia (covid-19) with high risk factors.

Active, not recruitingITMCTR2200005942

Shuguang Hospital Affiliated to Shanghai University of traditional Chinese MedicineCOVID-19

Start: 2022-05-01Updated: 2023-02-20

A real world study comparing the efficacy and safety of Jingyin granule and paxlovid in the treatment of novel coronavirus pneumonia (covid-19) with high risk factors

Active, not recruitingITMCTR2200005943

Shuguang Hospital Affiliated to Shanghai University of traditional Chinese MedicineCOVID-19

Start: 2022-05-01Updated: 2023-02-20